Siemens AG news
Merck and Pfizer Inc. (NYSE: PFE) today announced topline results of the Phase III JAVELIN Gastric 100 study evaluating avelumab as first-line maintenance therapy following induction chemotherapy in patients with unresectable, locally advanced or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) cancer versus continuation of chemotherapy or best supportive care. While the study showed clinical activity for avelumab in this setting, it did not meet the primary endpoints of su
Nerve transfer surgery has enabled 13 young adults with complete paralysis to regain movement and function in their elbows and hands, according to the largest case series of this technique in people with tetraplegia (paralysis of both the upper and lower limbs), published in The Lancet.
During the surgery, Australian surgeons attached functioning nerves above the spinal injury to paralysed nerves below the injury. Two years after
- Review indicates that menstrual cups are a safe option for menstruation management
- Around 70% of women wanted to continue using menstrual cups once they were familiar with how use them, but practice, peer support and training are key to initiation
- Although there are 199 brands of menstrual cup, and cups are available in 99 countries, awareness is low – cups were only mentioned in 21 of 69 websites containing educational materials on puber
The incidence of colon and rectal cancer in adults younger than 50 years has increased substantially over the latest available 10-year period in several high-income countries, going against a decline or stabilisation trend in the incidence of colorectal cancers within the overall populations of high-income countries.
This is according to an observational study published in The Lancet Gastroenterology & Hepatology journal, whic
Merck, a leading science and technology company, today hosted a panel discussion on the occasion of the 72nd World Health Assembly in Geneva, Switzerland. The panel entitled,“Leaving no one behind: from philanth